FDA Finalizes Guidance on Product Name Placement in Advertisements

The FDA finalized its guidance on drug advertisements, clarifying the legal requirements for companies in the placement of the product’s name — as well as its size, prominence and frequency in promotional labeling, and the juxtaposition between branded and active ingredient names.
Source: Drug Industry Daily